GESTAÇÃO E FEOCROMOCITOMA: REVISÃO DE LITERATURA ACERCA DESTA CONDIÇÃO

Authors

  • RODRIGO Unifacisa
  • Guilherme William Rabelo Ansolin
  • Ândrey Gabriel Nunes de Souza
  • Lucas Souza de Almeida
  • Marina Diniz Dias
  • MILLA PROTO DE MATTOS SABINO
  • Alice Marques Alvim de Oliveira
  • Mauro Junior Melo Moura
  • Bruna Cecchin
  • Arthur Japiassu Cavalcanti Mariano da Rocha
  • Ana Mozer Vieira de Jesus
  • Thiago Resende
  • TARIANA LUCENA DOS SANTOS
  • ELEN CARLA DE MELO
  • Mayra Dantas Moreira
  • Débora Morgana Bezerra da Costa
  • Maria Queiroga Pinto
  • Isabel Danielly Cavalcanti Pinto Benjamin
  • Ana Beatriz de Lima Figueira
  • José Thayrone Moura Teles
  • Tiago Wanderley Queiroga Lira
  • Isabelle Laís Oliveira dos Santos Lira
  • Laura Coelho Pires Rocha
  • Marcelo dos Santos Castro
  • André Luiz Siqueira da Silva
  • Barbara Louiza Gomes de Macedo
  • Felipe Hubechara do Rego Reis
  • Bruna Carolina Martins Rosa
  • Mariana Pereira de Souza
  • Julião Jerônimo Leite Junior
  • Mac Kenzy Alves de Lima
  • Jordana Wyara Aparecida Barbosa
  • fernanda ferradeira latorre

DOI:

https://doi.org/10.36557/pbpc.v3i2.63

Keywords:

Pheochromocytoma, Pregnancy, Alpha-adrenergic

Abstract

This article reviews pheochromocytoma in pregnancy, a rare and potentially fatal condition. Pheochromocytoma, a tumor of the chromaffin cells of the adrenal glands, can cause severe hypertension due to the excessive production of catecholamines, further complicating its diagnosis and treatment during pregnancy. The aim of this review is to provide an overview of the pathogenesis, clinical manifestations, and treatments associated with pheochromocytoma in pregnancy. The methodology included an analysis of updated medical literature, focusing on studies that addressed the incidence, diagnosis, treatment, and outcomes of pheochromocytoma in pregnant women. The results highlight that paradoxical supine hypertension and the similarity of symptoms to preeclampsia complicate the diagnosis. Studies show that early diagnosis, based on the measurement of fractionated metanephrines and magnetic resonance imaging, is crucial for reducing fetal mortality, which has significantly decreased over the past decades. Clinical management includes alpha-adrenergic blockade and, when necessary, beta-adrenergic blockade. Surgical intervention, especially in the early stages of pregnancy, is controversial but may be necessary in selected cases. Cesarean delivery is preferred to minimize maternal and fetal risks. The conclusion reaffirms the importance of early diagnosis and appropriate clinical management, personalized for each patient, aiming to improve maternal and fetal outcomes.

Published

2024-08-04

Issue

Section

Ciências da Saúde